ALS Investment Fund
Amsterdam, North Hollandalsinvestmentfund.com
Overview
A patient-led and patient-centric venture philanthropy fund with a single focus on investing in companies developing therapeutics and diagnostics for Amyotrophic Lateral Sclerosis (ALS). It was founded by ALS patients for ALS patients, and all returns on investments are re-invested to support further research and development.
Portfolio Companies
7
Website
alsinvestmentfund.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| VectorY Therapeutics | Nov 2023 | Series A | Co-investor |
| QurAlis | Mar 2023 | Series B | Co-investor |
| Prilenia Therapeutics | Apr 2022 | Series B Extension | Co-investor |
| Verge Labs | Dec 2021 | Series B | Co-investor |
| Bloom Science | Dec 2021 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
